Jianying Wang

Title: Innovations of Jianying Wang in Glycosylation Processes

Introduction

Jianying Wang is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of glycosylation, particularly in the preparation of nucleosides. His innovative approach has implications for the development of antiviral and anticancer therapies.

Latest Patents

Wang holds a patent for a process titled "One vessel stereoselective glycosylation of purines and pyrimidines." This patent describes a method for preparing 2',3' dideoxynucleosides, 2'-deoxynucleosides, and 2',3'-dideoxy-2',3'-didehydronucleosides. The process involves the synchronous addition of a stereoselecting moiety and a protected purine or pyrimidine base to 5-(S)-6-(protected-oxy)-4,5-dihydrofuran in the presence of a Lewis acid. This one vessel reaction simplifies the process by eliminating the need for separate preparation and purification of a 2'-substituted ribose derivative.

Career Highlights

Jianying Wang is affiliated with Emory University, where he continues to advance research in glycosylation techniques. His work has garnered attention for its potential applications in medicinal chemistry and drug development. Wang's innovative methods are paving the way for more efficient synthesis of important nucleoside analogs.

Collaborations

Wang collaborates with esteemed colleagues, including Julie Wurster and Dennis C Liotta. Their combined expertise enhances the research output and fosters a collaborative environment for innovation.

Conclusion

Jianying Wang's contributions to the field of glycosylation exemplify the impact of innovative processes in pharmaceutical development. His patent and ongoing research at Emory University highlight the importance of advancements in this area.